Jean‐Marc Tréluyer
Délégation Paris 5(FR)Twitter (United States)(US)Hôpital Necker-Enfants Malades(FR)Council of Independent Colleges(US)Inserm(FR)Inserm(FR)Université Paris Cité(FR)Sorbonne Paris Cité(FR)Hôpital Cochin(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)National Confidential Enquiry into Patient Outcome and Death(GB)Clinical Investigation Center Plurithematic Tours(FR)Hôpital Européen Georges-Pompidou(FR)Hôpital Européen(FR)CIC Rennes(FR)Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale(FR)Institut Cochin(FR)Bicêtre Hospital(FR)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, Pharmacological Effects and Toxicity Studies, Antibiotics Pharmacokinetics and Efficacy
Most-Cited Works
- → Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients(2020)3,146 cited
- → A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)(2010)547 cited
- → Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea(2016)482 cited
- → Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome(2015)374 cited
- → Islet-reactive CD8 + T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors(2018)255 cited
- → Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients(2020)